Teva settles in Israel on bribes

Teva has struck a settlement deal with Israeli authorities to end an investigation into “improper payments” relating to the firm’s operations in Mexico, Russia and Ukraine. The investigation related to activities – including bribing government officials – that ended in 2012 and over which Teva agreed a US$519 million US settlement more than a year ago (Generics bulletin, 6 January 2017, page 3).

More from Policy & Regulation

More from Generics Bulletin